Cargando…
Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
The CRISPR-Cas system of prokaryotic adaptive immunity displays features of a mechanism for directional, Lamarckian evolution. Indeed, this system modifies a specific locus in a bacterial or archaeal genome by inserting a piece of foreign DNA into a CRISPR array which results in acquired, heritable...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765028/ https://www.ncbi.nlm.nih.gov/pubmed/26912144 http://dx.doi.org/10.1186/s13062-016-0111-z |
_version_ | 1782417485911293952 |
---|---|
author | Koonin, Eugene V. Wolf, Yuri I. |
author_facet | Koonin, Eugene V. Wolf, Yuri I. |
author_sort | Koonin, Eugene V. |
collection | PubMed |
description | The CRISPR-Cas system of prokaryotic adaptive immunity displays features of a mechanism for directional, Lamarckian evolution. Indeed, this system modifies a specific locus in a bacterial or archaeal genome by inserting a piece of foreign DNA into a CRISPR array which results in acquired, heritable resistance to the cognate selfish element. A key element of the Lamarckian scheme is the specificity and directionality of the mutational process whereby an environmental cue causes only mutations that provide specific adaptations to the original challenge. In the case of adaptive immunity, the specificity of mutations is equivalent to self-nonself discrimination. Recent studies on the CRISPR mechanism have shown that the levels of discrimination can substantially differ such that in some CRISPR-Cas variants incorporation of DNA is random whereas discrimination occurs by selection of cells that carry cognate inserts. In other systems, a higher level of specificity appears to be achieved via specialized mechanisms. These findings emphasize the continuity between random and directed mutations and the critical importance of evolved mechanisms that govern the mutational process. Reviewers: This article has been reviewed by Yitzhak Pilpel, Martijn Huynen, and Bojan Zagrovic. |
format | Online Article Text |
id | pubmed-4765028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47650282016-02-25 Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms Koonin, Eugene V. Wolf, Yuri I. Biol Direct Opinion The CRISPR-Cas system of prokaryotic adaptive immunity displays features of a mechanism for directional, Lamarckian evolution. Indeed, this system modifies a specific locus in a bacterial or archaeal genome by inserting a piece of foreign DNA into a CRISPR array which results in acquired, heritable resistance to the cognate selfish element. A key element of the Lamarckian scheme is the specificity and directionality of the mutational process whereby an environmental cue causes only mutations that provide specific adaptations to the original challenge. In the case of adaptive immunity, the specificity of mutations is equivalent to self-nonself discrimination. Recent studies on the CRISPR mechanism have shown that the levels of discrimination can substantially differ such that in some CRISPR-Cas variants incorporation of DNA is random whereas discrimination occurs by selection of cells that carry cognate inserts. In other systems, a higher level of specificity appears to be achieved via specialized mechanisms. These findings emphasize the continuity between random and directed mutations and the critical importance of evolved mechanisms that govern the mutational process. Reviewers: This article has been reviewed by Yitzhak Pilpel, Martijn Huynen, and Bojan Zagrovic. BioMed Central 2016-02-24 /pmc/articles/PMC4765028/ /pubmed/26912144 http://dx.doi.org/10.1186/s13062-016-0111-z Text en © Koonin and Wolf. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Opinion Koonin, Eugene V. Wolf, Yuri I. Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
title | Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
title_full | Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
title_fullStr | Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
title_full_unstemmed | Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
title_short | Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
title_sort | just how lamarckian is crispr-cas immunity: the continuum of evolvability mechanisms |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765028/ https://www.ncbi.nlm.nih.gov/pubmed/26912144 http://dx.doi.org/10.1186/s13062-016-0111-z |
work_keys_str_mv | AT koonineugenev justhowlamarckianiscrisprcasimmunitythecontinuumofevolvabilitymechanisms AT wolfyurii justhowlamarckianiscrisprcasimmunitythecontinuumofevolvabilitymechanisms |